Both α1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice

Neuroscience Letters

Volumn 347, Issue 2, 2003, Pages 136-138

  Cheng, Juei Tang ^a   Kuo, Dong Yih ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

D1 receptor subtype; Food intake; Phenylpropanolamine

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; HALOPERIDOL; PHENTOLAMINE; PHENYLPROPANOLAMINE; PIMOZIDE; PRAZOSIN; PROPRANOLOL; RECEPTOR SUBTYPE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANOREXIGENIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; DRUG INHIBITION; FEEDING BEHAVIOR; FOOD INTAKE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; DRUG EFFECT; EATING; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; APPETITE DEPRESSANTS; DOPAMINE ANTAGONISTS; EATING; MALE; MICE; PHENYLPROPANOLAMINE; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D1; SYNAPTIC TRANSMISSION;

EID: 0038302329     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00637-2     Document Type: Article

References (19)

1. Barone P., Davis T.A., Braun A.R., Chase T.N. Dopaminergic mechanisms and motor function: characterization of D1 and D2 dopamine receptor interaction. Eur. J. Pharmacol. 123:1986;109-114.
2. Blosser J.C., Barrantes M., Parke R.B. Correlation between anorectic potency and affinity for hypothalamic (+)-amphetamine binding sites of phenylethylamines. Eur. J. Pharmacol. 134:1987;97-103.
3. Burridge S.L., Blundell J.E. Amphetamine anorexia: antagonism by typical but not atypical neuroleptics. Neuropharmacology. 18:1979;453-457.
4. Chen T.Y., Duh S.L., Huang C.C., Lin T.B., Kuo D.Y. Evidence for the involvement of dopamine D1 and D2 receptors in mediating the decrease of food intake during repeated treatment with amphetamine. J. Biomed. Sci. 8:2001;462-466.
5. Engberg G., Svensson T.H. Amphetamine-induced inhibition of central noradrenergic neurons: a pharmacological analysis. Life Sci. 24:1979;2245-2254.
6. Evans K.R., Eikelboom R. Feeding induced by ventricular bromocriptine and amphetamine: a possible excitatory role for dopamine in eating behavior. Behav. Neurosci. 10:1987;591-593.
7. Kuo D.Y., Cheng J.T. Role of cerebral dopamine but not plasma insulin, leptin and glucocorticoid in the development of tolerance to the anorectic effect of amphetamine. Neurosci. Res. 44:2002;63-69.
8. Lee F., Stafford I., Hoebel B.G. Similarities between the stimulus properties of phenylpropanolamine and amphetamine. Psychopharmacology. 97:1989;410-412.
9. Martin-Iverson M.T., Dourish C.T. Role of dopamine D1 and D2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology. 96:1988;370-374.
10. Morien A., Cassone V.M., Wellman P.J. Diurnal changes in paraventricular hypothalamic alpha1- and alpha2-adrenoceptors and food intake in rats. Pharmacol. Biochem. Behav. 63:1999;33-38.
11. Moya-Huff F., Maher T.J. Adrenergic receptor subtype activation by (+)-, (-)- and (±)-norephedrine in the pithed rat. J. Pharm. Pharmacol. 39:1987;108-112.
12. Schteingart D.E. Effectiveness of phenylpropanolamine in the management of moderate obesity. Int. J. Obes. 16:1992;487-493.
13. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 23:1993;639-677.
14. 2+ oscillations in the VTA dopamine neurons. NeuroReport. 11:2000;1057-1061.
15. Wellman P.J., Davies B.T. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the α1-adrenergic receptor antagonist prazosin. Pharmacol. Biochem. Behav. 42:1992;97-100.
16. Wellman P.J. Effects of haloperidol on anorexia induced by l-norephedrine and d-amphetamine in adult rats. Pharmacol. Biochem. Behav. 35:1990;457-460.
17. Winders S.E., Amos J.C., Wilson M.R., Rushing P.A., Dykstra T., Coday M.C. Effects of chronic phenylpropanolamine infusion and termination of body weight, food consumption and water consumption in rats. Psychopharmacology. 114:1994;513-519.
18. Winn P., Williams S.F., Herberg L.J. Feeding stimulated by very low doses of D-amphetamine administered systemically or by microinjection into the striatum. Psychopharmacology. 78:1983;336-341.
19. Yuan J., Callahan B.T., McCann U.D., Ricaurte G.A. Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity. J. Neurochem. 77:2001;1338-1347.